autoimmune-disease

Documents about autoimmune-disease

• Risk factors for immune checkpoint inhibitor colitis: a retrospective multi-center cohort study using electronic health records#620193eScholarship
• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes#982495ClinicalTrials.gov
• The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus#120197Europe PMC
• GLP1-E2 therapy delays autoimmune diabetes in late-stage prediabetic NOD mice and potentiates low-dose anti-CD3 therapy for enhanced disease protection#319403Springer Nature OA
• Coping Strategies, Loneliness, and Resilience in Patients With Dermatosis#888807ClinicalTrials.gov
• A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)#900864ClinicalTrials.gov
• Replication Data for: GLP1-E2 Therapy Delays Autoimmune Diabetes in Late-stage Prediabetic NOD Mice and Potentiates Low-dose Anti-CD3 Therapy for Enhanced Disease Protection#231862KU Leuven RDR Dataverse OAI Archive
• Outcome of patients with autoimmune diseases in the intensive care unit : A mixed cluster analysis#236925Repositorio institucional EdocUR
• Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10#871997ClinicalTrials.gov
• COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS#910358ClinicalTrials.gov
• Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia#979461ClinicalTrials.gov
• The role of JAK3 and TEC family kinases in vitiligo pathogenesis#121868HAL (France)
• Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity#865107ClinicalTrials.gov
• Controlling Hyperactive Immunity With Long-lived Lymphocytes#981396ClinicalTrials.gov
• The Knowns and Unknowns of Cardiac Autoimmunity in Viral Myocarditis#440473DigitalCommons@University of Nebraska
• Serum Soluble Programmed Death-1 Levels in Adult Immune Thrombocytopenic Purpura Patients and Their Relationship with Disease Duration and Clinical Characteristics#414910HAL (France)
• A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease#845891ClinicalTrials.gov
• Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance#865985ClinicalTrials.gov
• Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions#887526ClinicalTrials.gov
• Are minor alleles more likely to be risk alleles?#491823eScholarship
• An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients#871567ClinicalTrials.gov
• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)#884244ClinicalTrials.gov
• Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis#1046419ClinicalTrials.gov
• Cohort Study on Neuroimmune Diseases in the Reproductive Age#806933ClinicalTrials.gov
• Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study#996341eScholarship
• A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease#889908ClinicalTrials.gov
• KYSA-7: A Study of Anti-CD19 CAR T-Cell Therapy, in Subjects With Refractory Primary and Secondary Progressive Multiple Sclerosis#876724ClinicalTrials.gov
• An Integrated Map of Cell Type–Specific Gene Expression in Pancreatic Islets#922163eScholarship
• Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy#1010481ClinicalTrials.gov
• Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis#849820ClinicalTrials.gov
• Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis#491809eScholarship
• Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial#612076eScholarship
• Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens#612269eScholarship
• Hypoglycaemia Was Not Associated With Depression, Anxiety, Diabetes Distress or Fear of Hypoglycaemia Scores in People With Type 1 or Insulin-Treated Type 2 Diabetes in the Hypo-METRICS Study.#453979Apollo
• KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis#847923ClinicalTrials.gov
• Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research#664944eScholarship
• PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity#675979eScholarship
• ABCD of IA: A multi-scale agent-based model of T cell activation in inflammatory arthritis#983452eScholarship
• RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways#492020eScholarship
• Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)#981381ClinicalTrials.gov
• A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)#839456ClinicalTrials.gov